Skip to main content

Medications for Atrial Fibrillation

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
ibutilide 10 1 review for ibutilide to treat Atrial Fibrillation
Rx C N
Generic name:
ibutilide systemic
Brand name:
Corvert
Drug class:
group III antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Rythmol SR 8.7 15 reviews for Rythmol SR to treat Atrial Fibrillation
Rx C N
Generic name:
propafenone systemic
Drug class:
group I antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
propafenone 8.2 61 reviews for propafenone to treat Atrial Fibrillation
Rx C N
Generic name:
propafenone systemic
Brand name:
Rythmol SR
Drug class:
group I antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
flecainide 7.4 122 reviews for flecainide to treat Atrial Fibrillation
Rx C N
Generic name:
flecainide systemic
Brand name:
Tambocor
Drug class:
group I antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Tambocor 7.4 12 reviews for Tambocor to treat Atrial Fibrillation
Rx C N
Generic name:
flecainide systemic
Drug class:
group I antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Multaq 7.0 39 reviews for Multaq to treat Atrial Fibrillation
Rx X N
Generic name:
dronedarone systemic
Drug class:
group III antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
sotalol 7.0 43 reviews for sotalol to treat Atrial Fibrillation
Rx B N X
Generic name:
sotalol systemic
Brand name:
Sotylize
Drug class:
non-cardioselective beta blockers, group III antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
diltiazem 6.8 55 reviews for diltiazem to treat Atrial Fibrillation
Rx C N X
Generic name:
diltiazem systemic
Drug class:
calcium channel blocking agents, group IV antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
dronedarone 6.6 49 reviews for dronedarone to treat Atrial Fibrillation
Rx X N
Generic name:
dronedarone systemic
Brand name:
Multaq
Drug class:
group III antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Coreg Off-label 6.0 1 review for Coreg to treat Atrial Fibrillation
Rx C N X
Generic name:
carvedilol systemic
Drug class:
non-cardioselective beta blockers
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Off-label:
Yes
Coreg CR Off-label 6.0 1 review for Coreg CR to treat Atrial Fibrillation
Rx C N X
Generic name:
carvedilol systemic
Drug class:
non-cardioselective beta blockers
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Off-label:
Yes
digoxin 5.8 13 reviews for digoxin to treat Atrial Fibrillation
Rx C N
Generic name:
digoxin systemic
Brand names:
Lanoxin, Digox, Digitek
Drug class:
inotropic agents, group V antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
metoprolol Off-label 5.4 87 reviews for metoprolol to treat Atrial Fibrillation
Rx C N X
Generic name:
metoprolol systemic
Drug class:
cardioselective beta blockers
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
carvedilol Off-label 4.7 20 reviews for carvedilol to treat Atrial Fibrillation
Rx C N X
Generic name:
carvedilol systemic
Brand names:
Coreg, Coreg CR
Drug class:
non-cardioselective beta blockers
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
rivaroxaban 4.3 70 reviews for rivaroxaban to treat Atrial Fibrillation
Rx C N
Generic name:
rivaroxaban systemic
Brand name:
Xarelto
Drug class:
factor Xa inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Xarelto 4.3 65 reviews for Xarelto to treat Atrial Fibrillation
Rx C N
Generic name:
rivaroxaban systemic
Drug class:
factor Xa inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
edoxaban 4.0 2 reviews for edoxaban to treat Atrial Fibrillation
Rx C N
Generic name:
edoxaban systemic
Brand name:
Savaysa
Drug class:
factor Xa inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Savaysa 1.0 1 review for Savaysa to treat Atrial Fibrillation
Rx C N
Generic name:
edoxaban systemic
Drug class:
factor Xa inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Brevibloc Rate Add review
Rx C N X
Generic name:
esmolol systemic
Drug class:
cardioselective beta blockers, group II antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
clonidine Off-label Rate Add review
Rx C N X
Generic name:
clonidine systemic
Drug class:
antiadrenergic agents, centrally acting
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
Corvert Rate Add review
Rx C N
Generic name:
ibutilide systemic
Drug class:
group III antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Digitek Rate Add review
Rx C N
Generic name:
digoxin systemic
Drug class:
inotropic agents, group V antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Digox Rate Add review
Rx C N
Generic name:
digoxin systemic
For consumers:
dosage, interactions, side effects
esmolol Rate Add review
Rx C N X
Generic name:
esmolol systemic
Brand name:
Brevibloc
Drug class:
cardioselective beta blockers, group II antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Lanoxin Rate Add review
Rx C N
Generic name:
digoxin systemic
Drug class:
inotropic agents, group V antiarrhythmics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Learn more about Atrial Fibrillation

Care guides

Symptoms and treatments

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.